SCHEMBL7989011

SCHEMBL7989011

COc1cccc(-c2nc(=O)c3c(ncn3CCc3ccccc3)[nH]2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.48
▸ CNOT7 Q9UIV1 3/20 0.47
▸ HPGD P15428 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ GAA P10253 1/20 0.43
▸ PIN1 Q13526 1/20 0.42
▸ USP2 O75604 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ CLK4 Q9HAZ1 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984902 0.94 CNOT7 (0.49) KDM4ECNOT7HPGDALDH1A1MAPT
SCHEMBL7974586 0.90 GAA (0.52) CNOT7MAPTGAAPIN1TP53
SCHEMBL7985852 0.87 TP53 (0.52) MAPTGAALMNATP53
SCHEMBL7974620 0.86 CNOT7 (0.58) KDM4ECNOT7ALDH1A1LMNAMAPK1
SCHEMBL7974021 0.86 TP53 (0.51) CNOT7ALDH1A1MAPTGAAUSP2
SCHEMBL7984686 0.85 CNOT7 (0.50) KDM4ECNOT7ALDH1A1PIN1LMNA
SCHEMBL7988553 0.85 CNOT7 (0.50) CNOT7ALDH1A1PIN1
SCHEMBL7984409 0.85 CNOT7 (0.53) KDM4ECNOT7ALDH1A1LMNAMAPK1
SCHEMBL7988586 0.85 CNOT7 (0.50) KDM4ECNOT7HPGDALDH1A1MAPT
SCHEMBL7989007 0.84 GAA (0.50) KDM4EHPGDALDH1A1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 — — US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 — — EP disclosed
Send feedback